NEW PRODUCTS
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 112191 | Aprocitentan | 1103522-45-7 | 98% Min. |  |
| Aprocitentan is an orally active, dual endothelin (ET) receptor antagonist developed | ||||
| 6121401 | Vadadustat ( AKB-6548 ) | 1000025-07-9 | 98% | _1000025-07-9.png) |
| Vadadustat (AKB-6548), a novel, titratable, oral hypoxia-inducible factor prolyl hydr | ||||
| 1662118 | MK-8931 ( Verubecestat ) | 1286770-55-5 | 98% by HPLC/HNMR | -cas-1286770-55-5.png) |
| Verubecestat(MK-8931) is a small-molecule inhibitor of beta-secretase cleaving enzyme | ||||
| 6112701 | JPH203 ( KYT-0353 ) | 1037592-40-7 | ≧98.0% | _1037592-40-7.png) |
| JPH203(also known as KYT-0353) is a potent and selective LAT1 selective ( L-type amin | ||||
| 615201 | CLEFMA | 1246964-32-8 | 98% Min. |  |
| CLEFMA has anti-proliferative activity in H441 cells. CLEFMA may induce autophagic ce | ||||
| 174192 | RG7800 ( RO6885247 ) | 1449598-06-4 | ≧98.0% | _1449598-06-4.png) |
| RG7800(RO6885247) is a small molecule modifier of survival motor neuron 2 splicing. | ||||
| 111013 | MGCD-265-analog | 875337-44-3 | ≧98.0% |  |
| MGCD-265-analog is a tyrosine kinase inhibitor that selectively targets MET and Axl.M | ||||
| 121805 | L-778123 hydrochloride | 253863-00-2 | 98% |  |
| L-778123 hydrochloride is an inhibitor of FPTase and GGPTase-I with IC50 of 2 nM and | ||||
| 51703 | Luminespib ( NVP-AUY922 ; VER-52296 ) | 747412-49-3 | 98% | _747412-49-3.png) |
| NVP-AUY922 is an experimental drug candidate for the treatment of cancer. It was disc | ||||
| 122805 | Balipodect ( TAK-063 ) | 1238697-26-1 | 98% | _1238697-26-1.png) |
| Balipodect (TAK 063 ) is a novel PDE10A inhibitor. It has shown high inhibitory activ | ||||
| 51608 | SSR128129E | 848318-25-2 | 98% |  |
| SSR128129E is an orally-active and allostericFGFR1inhibitor withIC50of 1.9 M, while n | ||||
| 71161 | SBI0206965 | 1884220-36-3 | 98% |  |
| SBI0206965 is a potent and selective autophagy Kinase ULK1 Inhibitor. Many tumors bec | ||||